Pharmaceutical companies face increasing pricing pressure on new medicines, and many have turned to automation to shorten product development timelines, facilitate compliance and reduce costs. By automating repetitive manual tasks, such as..
Articles by:Célia Gasselin
Recent Posts
We are in the Age of Information. The recent exponential increase in computational power now enables data-driven decisions across organizations, streamlining workflows and improving efficiency. Therefore, many companies are searching for the best..
In preclinical drug development, in vivo studies are a mandatory step in the process of turning lead compounds into drug candidates. Regulatory agencies require in vivo safety and efficacy data from animal models before approving novel candidates..
We all expect that the medicine we receive is safe and effective. For pharmaceutical products to meet these requirements, regulatory authorities, such as the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA), ensure..
Drug discovery and development lead to new treatments for diseases. However, it is a costly, time-consuming and challenging process—developing a marketable drug can take more than 10 years and cost around a billion dollars. One of the reasons for..
When the human genome was sequenced in 2003, it became possible to identify the gene and protein changes that occur in various diseases, such as cancer. Ever since, the field of proteomics has been booming to respond to the ever-increasing..
